Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA

Simple item page
dc.contributor.authorDhureja, Maanvi
dc.contributor.authorArthur, Richmond
dc.contributor.authorSoni, Divya
dc.contributor.authorUpadhayay, Shubham
dc.contributor.authorTemgire, Pooja
dc.contributor.authorKumar, Puneet
dc.date.accessioned2024-01-21T10:55:19Z
dc.date.accessioned2024-08-14T07:44:16Z
dc.date.available2024-01-21T10:55:19Z
dc.date.available2024-08-14T07:44:16Z
dc.date.issued2023-11-16T00:00:00
dc.description.abstractIntroduction: Recent neuroscience breakthroughs have shed light on the sophisticated relationship between calcium channelopathies and movement disorders, exposing a previously undiscovered tale focusing on the Ryanodine Receptor (RyR) and the Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA). Calcium signaling mainly orchestrates neural communication, which regulates synaptic transmission and total network activity. It has been determined that RyR play a significant role in managing neuronal functions, most notably in releasing intracellular calcium from the endoplasmic reticulum. Areas covered: It highlights the involvement of calcium channels such as RyR and SERCA in physiological and pathophysiological conditions. Expert opinion: Links between RyR and SERCA activity dysregulation, aberrant calcium levels, motor and cognitive dysfunction have brought attention to the importance of RyR and SERCA modulation in neurodegenerative disorders. Understanding the obscure function of these proteins will open up new therapeutic possibilities to address the underlying causes of neurodegenerative diseases. The unreported RyR and SERCA narrative broadens the understanding of calcium channelopathies in movement disorders and calls for more research into cutting-edge therapeutic approaches. � 2023 Informa UK Limited, trading as Taylor & Francis Group.en_US
dc.identifier.doi10.1080/14728222.2023.2277863
dc.identifier.issn14728222
dc.identifier.urihttp://10.2.3.109/handle/32116/4401
dc.identifier.urlhttps://www.tandfonline.com/doi/full/10.1080/14728222.2023.2277863
dc.language.isoen_USen_US
dc.publisherTaylor and Francis Ltd.en_US
dc.subjectCalciumen_US
dc.subjectExcitotoxicityen_US
dc.subjectneurodegenerationen_US
dc.subjectryanodine receptoren_US
dc.subjectSERCA pumpen_US
dc.titleCalcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCAen_US
dc.title.journalExpert Opinion on Therapeutic Targetsen_US
dc.typeReviewen_US
dc.type.accesstypeClosed Accessen_US

Files

Collections

Pharmacology - Research Publications